Tesamorelin / Ipamorelin Blend 18mg

Tesamorelin / Ipamorelin 18mg Blend

Tesamorelin / Ipamorelin 18mg Blend is presented in a laboratory-use format for structured cataloging, product identification, and research reference within the Riptidez research collection.

This blended research material is commonly referenced in laboratory discussion involving growth hormone signaling pathways, endocrine communication systems, receptor activity, and peptide-based research models.

Product Details

• Product Name: Tesamorelin / Ipamorelin Blend
• Total Content: 18 mg
• Composition: 12 mg Tesamorelin / 6 mg Ipamorelin
• Form: Lyophilized peptide powder
• Container: 3 mL research vial
• Intended Use: Laboratory research only

Research Context

Tesamorelin is studied in controlled laboratory environments for its interaction with growth hormone-releasing hormone (GHRH) signaling pathways. Ipamorelin is examined for its selective interaction with ghrelin receptor pathways and related peptide signaling systems.

When referenced together in research settings, these compounds are commonly discussed in connection with endocrine communication, receptor-mediated signaling, and broader growth hormone pathway investigation within experimental models.

Handling & Storage

• Store lyophilized material in a cool, dry, dark environment
• Avoid exposure to heat, moisture, and direct light
• After reconstitution, store at 2–8°C (35.6–46.4°F)
• Avoid repeated freeze–thaw cycles
• Use standard sterile laboratory handling techniques

Explore Related Research

• Tesamorelin / Ipamorelin Research Overview
• Ipamorelin Research Overview
• CJC-1295 Research Overview
• Growth Hormone Signaling Research
• Research Library

Disclaimer: This product is intended strictly for laboratory research purposes only. Not for human consumption, veterinary use, or therapeutic application.